Clinical Trial Update: Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness [Phase 4]

View source ↗

Summary

A Phase 4 exploratory trial evaluating the effects of darifenacin on nocturia, sleep, and daytime wakefulness has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Darifenacin (darifenacin)

Snippet

Sponsor: Cognitive Research Corporation | Conditions: Nocturia | Phase 4 | Status: WITHDRAWN